The hemopoietic action of androstanes.
D000731:Androstanes / Q000009:adverse effects / Q000627:therapeutic use*; D000741:Anemia, Aplastic / Q000151:congenital / Q000188:drug therapy; D000756:Anemia, Sideroblastic / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects; D001855:Bone Marrow Diseases / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects; D005938:Glucocorticoids / Q000627:therapeutic use; D006130:Growth Disorders / Q000139:chemically induced; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007938:Leukemia / Q000188:drug therapy; D008099:Liver / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D009504:Neutrophils / Q000187:drug effects; D055728:Primary Myelofibrosis / Q000188:drug therapy; D013945:Thymoma / Q000188:drug therapy; D014770:Virilism / Q000139:chemically induced; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000731:Androstanes; D005938:Glucocorticoids